Description
In this webinar, our panel of experts will examine how to navigate pricing and reimbursement challenges for rare disease technologies.
In this webinar you will:
– Understand the role of Patient Advocacy Groups (PAGs) and how a PAG’s perspective can effectively be captured earlier in the reimbursement process
– Gain an overview of current system changes and challenges
– Understand the evidence needs for defining value in rare diseases
– Recognise the difficulties around collecting data to support reimbursement, creating evidence packages, and the extra planning needed with clinical trials
– Learn from PAGs’ success stories on what has worked well and suggestions on how BioPharma companies can partner with PAGs to improve patient outcomes
– Understand how to optimise the likelihood of successful reimbursement in the UK and EU
Please note, this webinar is only available to BioPharma companies. This webinar will be recorded and distributed after the session.
Your Questions Matter
To get the most value from this interactive session, please send us your questions in advance. We will put them to the panel and do our best to ensure your specific issues are addressed. Email questions for the panel to [email protected]
Register via this link: https://bit.ly/3I0eQmr
Images
